Inventor · disambiguated record
Xanthe M. Lam
Also filed as: LAM XANTHE · LAM XANTHE M · WU SYLVIA SAU-YAN
16 granted patents·6 pending applications·4,346 citations·filing 1996–2015
96Inventor score
Top patents by PatentIndex Score
22 records- 0198US7682609B2Protein formulationGENENTECH INC·Filed 2006·Granted Mar 23, 2010·77 cites·30 claims
- 0298US7060268B2Protein formulationGENENTECH INC·Filed 2003·Granted Jun 13, 2006·208 cites·3 claims
- 0398US6821515B1Protein formulationGENENTECH INC·Filed 2000·Granted Nov 23, 2004·209 cites·23 claims
- 0498US6685940B2Protein formulationGENENTECH INC·Filed 2001·Granted Feb 3, 2004·402 cites·15 claims
- 0598US6267958B1Protein formulationGENENTECH INC·Filed 1996·Granted Jul 31, 2001·1.5k cites·47 claims
- 0697US6171586B1Antibody formulationGENENTECH INC·Filed 1998·Granted Jan 9, 2001·1.6k cites·29 claims
- 0796US7651703B2Injection vehicle for polymer-based formulationsGENENTECH INC·Filed 2006·Granted Jan 26, 2010·41 cites·22 claims
- 0895US9283273B2Protein formulationANDYA JAMES·Filed 2012·Granted Mar 15, 2016·20 cites·16 claims
- 0995US6991790B1Antibody formulationGENENTECH INC·Filed 2000·Granted Jan 31, 2006·104 cites·20 claims
- 1092US7582311B1Injection vehicle for polymer-based formulationsGENENTECH INC·Filed 2000·Granted Sep 1, 2009·52 cites·44 claims
- 1189US6113947AControlled release microencapsulated NGF formulationGENENTECH INC·Filed 1997·Granted Sep 5, 2000·94 cites·31 claims
- 1285US9266961B2Anti-PCSK9 antibodies, formulations, dosing, and methods of useGENENTECH INC·Filed 2013·Granted Feb 23, 2016·8 cites·42 claims
- 1378US7163701B2Controlled release microencapsulated NGF formulationGENENTECH INC·Filed 2003·Granted Jan 16, 2007·7 cites·11 claims
- 1463US6663899B2Controlled release microencapsulated NGF formulationGENENTECH INC·Filed 1998·Granted Dec 16, 2003·12 cites·31 claims
- 1560US2010330184A1Injection vehicle for polymer-based formulationsCLELAND JEFFREY L·Filed 2009·Application pending·0 cites
- 1659US2011236383A1Protein FormulationANDYA JAMES·Filed 2011·Application pending·0 cites
- 1758US2010158899A1Protein formulationGENENTECH INC·Filed 2010·Application pending·0 cites
- 1855US2004097417A1Stabilizing formulation for NGFFiled 2003·Application pending·0 cites
- 1954US6964947B1Stabilizing formulation for NGFGENENTECH INC·Filed 2000·Granted Nov 15, 2005·0 cites·5 claims
- 2049US2005158316A1Antibody formulationGENENTECH INC·Filed 2005·Application pending·0 cites
- 2145US6090781AStabilizing formulation for NGFGENENTECH INC·Filed 1996·Granted Jul 18, 2000·11 cites·1 claims
- 2243US2016355606A1Anti-pcsk9 antibodies, formulations, dosing, and methods of useGENENTECH INC·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →